二尖瓣术后新发心房颤动
该研究纳入2004至2014年接受二尖瓣手术且术前无心房颤动病史的1288例患者,其中930例有术后90天以上节律信息。新发心房颤动5年和10年发生率分别为14%和23%,三尖瓣手术、主动脉瓣手术和年龄增长是多变量风险因素,新发心房颤动未影响总体生存,但卒中风险呈强趋势增加。
要点
- 二尖瓣术后新发心房颤动5年和10年发生率分别为14%和23%。
- 三尖瓣手术(HR 1.80)、主动脉瓣手术(HR 1.49)和年龄增长(HR 1.03)是多变量风险因素。
- 新发心房颤动未影响总体生存(P = .41),卒中风险呈强趋势增加(P = .055)。
核心结论
- 二尖瓣术后新发心房颤动呈渐进性发生,且与卒中风险呈强趋势增加相关。
- 作者认为高风险患者可纳入试验以降低心房颤动的发生。
研究设计与样本
- 回顾性队列研究,纳入2004至2014年接受二尖瓣手术的2261例患者。
- 其中1288例(57%)无术前心房颤动病史,930例有术后90天以上节律信息。
- 采用半竞争风险多状态模型估计新发心房颤动和死亡概率,采用Fine-Gray模型识别风险因素。
主要发现
- 新发心房颤动5年和10年发生率分别为14%和23%。
- 单变量风险因素包括年龄较大、手术更复杂、三尖瓣反流更重和充血性心力衰竭(均P < .05)。
- 退行性二尖瓣反流患者发生心房颤动的可能性较低(HR 0.4;95%CI 0.24-0.65;P < .001)。
- 多变量风险因素为三尖瓣手术(HR 1.80;95%CI 1.22-2.65;P = .003)、主动脉瓣手术(HR 1.49;95%CI 1.03-2.17;P = .035)和年龄较大(HR 1.03;95%CI 1.02-1.05;P < .001)。
- 新发心房颤动未影响总体生存(P = .41);发生新发心房颤动的患者华法林使用增加(P < .001),卒中风险呈强趋势增加(P = .055)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to determine the incidence and risk factors for de novo atrial fibrillation (>90 days after surgery) in patients without preoperative atrial fibrillation. METHODS: From 2004 to 2014, 2261 patients underwent mitral valve surgery; 1288 patients (57%) did not have a history of atrial fibrillation, and 930 patients had rhythm information more than 90 days after surgery. De novo atrial fibrillation and death probabilities were estimated using a semi-competing risks, multi-state model. Univariable and multivariable risk factors for developing atrial fibrillation were identified using the Fine-Gray model. RESULTS: The 5- and 10-year incidences of de novo atrial fibrillation were 14% and 23%, respectively. Univariable risk factors were older age, more complex operations, more tricuspid regurgitation, and congestive heart failure (all P < .05). Patients with degenerative mitral regurgitation were less likely to develop atrial fibrillation (hazard ratio [HR], 0.4; 95% confidence interval [CI], 0.24-0.65; P < .001). Multivariable risk factors for de novo atrial fibrillation were tricuspid valve surgery (HR, 1.80; 95% CI, 1.22, 2.65; P = .003), aortic valve surgery (HR, 1.49; 95% CI, 1.03-2.17; P = .035), and older age (HR, 1.03; 95% CI, 1.02-1.05; P < .001). De novo atrial fibrillation did not affect overall survival (P = .41). Among patients who developed de novo atrial fibrillation, we observed increased use of warfarin (P < .001) and a strong trend toward an increased risk of stroke (P = .055). CONCLUSIONS: De novo atrial fibrillation develops progressively after mitral surgery and is associated with a strong trend toward stroke. Patients at high risk could be studied in a trial to reduce atrial fibrillation.
引用
- Mehta CK, McCarthy PM, Andrei AC, et al. De novo atrial fibrillation after mitral valve surgery. J Thorac Cardiovasc Surg. 2018. PMID: 30248793. doi:10.1016/j.jtcvs.2018.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。